BRIDGEBIO PHARMA INC. - COMMON STOCK
25.23
04-10月-24 15:59:59
15 分の遅延
株式
-0.40
-1.56%
本日の幅
25.12 - 26.05
ISIN
N/A
ソース
NASDAQ
-
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
03 8 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
18 7 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
17 7 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
14 7 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
12 7 2023 16:31:00 提供 Nasdaq GlobeNewswire
-
20 6 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13 6 2023 09:33:35 提供 Nasdaq GlobeNewswire
-
15 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
04 5 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference
27 4 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11 4 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07 4 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
23 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
BridgeBio Pharma Announces Pricing of Public Offering of Common Stock
08 3 2023 07:00:01 提供 Nasdaq GlobeNewswire